The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease.
Identifieur interne : 003321 ( PubMed/Curation ); précédent : 003320; suivant : 003322The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease.
Auteurs : J J Brugts [Pays-Bas] ; Hisatomi Arima [Australie] ; W. Remme [Pays-Bas] ; M. Bertrand [France] ; R. Ferrari [Italie] ; K. Fox [Royaume-Uni] ; J. Dinicolantonio [États-Unis] ; S. Macmahon [Australie] ; J. Chalmers [Australie] ; F. Zijlstra [Pays-Bas] ; K. Caliskan [Pays-Bas] ; M L Simoons [Pays-Bas] ; J J Mourad [France] ; E. Boersma [Pays-Bas] ; K M Akkerhuis [Pays-Bas]Source :
- International journal of cardiology [ 1874-1754 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Facteurs de l'âge, Facteurs sexuels, Femelle, Humains, Incidence, Inhibiteurs de l'enzyme de conversion de l'angiotensine (effets indésirables), Maladies vasculaires (traitement médicamenteux), Maladies vasculaires (épidémiologie), Mâle, Périndopril (effets indésirables), Sujet âgé, Toux (), Toux (diagnostic), Toux (épidémiologie), Valeur prédictive des tests, Études de suivi.
- MESH :
- diagnostic : Toux.
- effets indésirables : Inhibiteurs de l'enzyme de conversion de l'angiotensine, Périndopril.
- traitement médicamenteux : Maladies vasculaires.
- épidémiologie : Maladies vasculaires, Toux.
- Adulte d'âge moyen, Facteurs de l'âge, Facteurs sexuels, Femelle, Humains, Incidence, Mâle, Sujet âgé, Toux, Valeur prédictive des tests, Études de suivi.
English descriptors
- KwdEn :
- Age Factors, Aged, Angiotensin-Converting Enzyme Inhibitors (adverse effects), Cough (chemically induced), Cough (diagnosis), Cough (epidemiology), Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Perindopril (adverse effects), Predictive Value of Tests, Sex Factors, Vascular Diseases (drug therapy), Vascular Diseases (epidemiology).
- MESH :
- chemical , adverse effects : Angiotensin-Converting Enzyme Inhibitors, Perindopril.
- chemically induced : Cough.
- diagnosis : Cough.
- drug therapy : Vascular Diseases.
- epidemiology : Cough, Vascular Diseases.
- Age Factors, Aged, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Predictive Value of Tests, Sex Factors.
Abstract
Our objective was to investigate the actual incidence and clinical determinants of cough leading to discontinuation of ACE-inhibitors. Cough is the most frequent reason to stop ACE-inhibitor treatment.
DOI: 10.1016/j.ijcard.2014.07.108
PubMed: 25189490
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003434
Links to Exploration step
pubmed:25189490Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease.</title><author><name sortKey="Brugts, J J" sort="Brugts, J J" uniqKey="Brugts J" first="J J" last="Brugts">J J Brugts</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands. Electronic address: j.brugts@erasmusmc.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam</wicri:regionArea></affiliation></author><author><name sortKey="Arima, Hisatomi" sort="Arima, Hisatomi" uniqKey="Arima H" first="Hisatomi" last="Arima">Hisatomi Arima</name><affiliation wicri:level="1"><nlm:affiliation>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW</wicri:regionArea></affiliation></author><author><name sortKey="Remme, W" sort="Remme, W" uniqKey="Remme W" first="W" last="Remme">W. Remme</name><affiliation wicri:level="1"><nlm:affiliation>STICARES Cardiovascular Research Institute, Rhoon, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>STICARES Cardiovascular Research Institute, Rhoon</wicri:regionArea></affiliation></author><author><name sortKey="Bertrand, M" sort="Bertrand, M" uniqKey="Bertrand M" first="M" last="Bertrand">M. Bertrand</name><affiliation wicri:level="1"><nlm:affiliation>Lille Heart Institute, Lille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Lille Heart Institute, Lille</wicri:regionArea></affiliation></author><author><name sortKey="Ferrari, R" sort="Ferrari, R" uniqKey="Ferrari R" first="R" last="Ferrari">R. Ferrari</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, University of Ferrara, Salvatore Maugeri Foundation, IRCCS, Ferrara, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Cardiology, University of Ferrara, Salvatore Maugeri Foundation, IRCCS, Ferrara</wicri:regionArea></affiliation></author><author><name sortKey="Fox, K" sort="Fox, K" uniqKey="Fox K" first="K" last="Fox">K. Fox</name><affiliation wicri:level="1"><nlm:affiliation>NHLI, Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>NHLI, Imperial College, ICMS, Royal Brompton Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Dinicolantonio, J" sort="Dinicolantonio, J" uniqKey="Dinicolantonio J" first="J" last="Dinicolantonio">J. Dinicolantonio</name><affiliation wicri:level="1"><nlm:affiliation>Mid-America Heart Institute, Saint Luke's Hospital, KS City, MO, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Mid-America Heart Institute, Saint Luke's Hospital, KS City, MO</wicri:regionArea></affiliation></author><author><name sortKey="Macmahon, S" sort="Macmahon, S" uniqKey="Macmahon S" first="S" last="Macmahon">S. Macmahon</name><affiliation wicri:level="1"><nlm:affiliation>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW</wicri:regionArea></affiliation></author><author><name sortKey="Chalmers, J" sort="Chalmers, J" uniqKey="Chalmers J" first="J" last="Chalmers">J. Chalmers</name><affiliation wicri:level="1"><nlm:affiliation>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW</wicri:regionArea></affiliation></author><author><name sortKey="Zijlstra, F" sort="Zijlstra, F" uniqKey="Zijlstra F" first="F" last="Zijlstra">F. Zijlstra</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam</wicri:regionArea></affiliation></author><author><name sortKey="Caliskan, K" sort="Caliskan, K" uniqKey="Caliskan K" first="K" last="Caliskan">K. Caliskan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam</wicri:regionArea></affiliation></author><author><name sortKey="Simoons, M L" sort="Simoons, M L" uniqKey="Simoons M" first="M L" last="Simoons">M L Simoons</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam</wicri:regionArea></affiliation></author><author><name sortKey="Mourad, J J" sort="Mourad, J J" uniqKey="Mourad J" first="J J" last="Mourad">J J Mourad</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine and Arterial Hypertension, CHJ Avicenne, APHP, Bobigny, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Internal Medicine and Arterial Hypertension, CHJ Avicenne, APHP, Bobigny</wicri:regionArea></affiliation></author><author><name sortKey="Boersma, E" sort="Boersma, E" uniqKey="Boersma E" first="E" last="Boersma">E. Boersma</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam</wicri:regionArea></affiliation></author><author><name sortKey="Akkerhuis, K M" sort="Akkerhuis, K M" uniqKey="Akkerhuis K" first="K M" last="Akkerhuis">K M Akkerhuis</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25189490</idno><idno type="pmid">25189490</idno><idno type="doi">10.1016/j.ijcard.2014.07.108</idno><idno type="wicri:Area/PubMed/Corpus">003434</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003434</idno><idno type="wicri:Area/PubMed/Curation">003321</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003321</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease.</title><author><name sortKey="Brugts, J J" sort="Brugts, J J" uniqKey="Brugts J" first="J J" last="Brugts">J J Brugts</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands. Electronic address: j.brugts@erasmusmc.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam</wicri:regionArea></affiliation></author><author><name sortKey="Arima, Hisatomi" sort="Arima, Hisatomi" uniqKey="Arima H" first="Hisatomi" last="Arima">Hisatomi Arima</name><affiliation wicri:level="1"><nlm:affiliation>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW</wicri:regionArea></affiliation></author><author><name sortKey="Remme, W" sort="Remme, W" uniqKey="Remme W" first="W" last="Remme">W. Remme</name><affiliation wicri:level="1"><nlm:affiliation>STICARES Cardiovascular Research Institute, Rhoon, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>STICARES Cardiovascular Research Institute, Rhoon</wicri:regionArea></affiliation></author><author><name sortKey="Bertrand, M" sort="Bertrand, M" uniqKey="Bertrand M" first="M" last="Bertrand">M. Bertrand</name><affiliation wicri:level="1"><nlm:affiliation>Lille Heart Institute, Lille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Lille Heart Institute, Lille</wicri:regionArea></affiliation></author><author><name sortKey="Ferrari, R" sort="Ferrari, R" uniqKey="Ferrari R" first="R" last="Ferrari">R. Ferrari</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, University of Ferrara, Salvatore Maugeri Foundation, IRCCS, Ferrara, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Cardiology, University of Ferrara, Salvatore Maugeri Foundation, IRCCS, Ferrara</wicri:regionArea></affiliation></author><author><name sortKey="Fox, K" sort="Fox, K" uniqKey="Fox K" first="K" last="Fox">K. Fox</name><affiliation wicri:level="1"><nlm:affiliation>NHLI, Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>NHLI, Imperial College, ICMS, Royal Brompton Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Dinicolantonio, J" sort="Dinicolantonio, J" uniqKey="Dinicolantonio J" first="J" last="Dinicolantonio">J. Dinicolantonio</name><affiliation wicri:level="1"><nlm:affiliation>Mid-America Heart Institute, Saint Luke's Hospital, KS City, MO, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Mid-America Heart Institute, Saint Luke's Hospital, KS City, MO</wicri:regionArea></affiliation></author><author><name sortKey="Macmahon, S" sort="Macmahon, S" uniqKey="Macmahon S" first="S" last="Macmahon">S. Macmahon</name><affiliation wicri:level="1"><nlm:affiliation>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW</wicri:regionArea></affiliation></author><author><name sortKey="Chalmers, J" sort="Chalmers, J" uniqKey="Chalmers J" first="J" last="Chalmers">J. Chalmers</name><affiliation wicri:level="1"><nlm:affiliation>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW</wicri:regionArea></affiliation></author><author><name sortKey="Zijlstra, F" sort="Zijlstra, F" uniqKey="Zijlstra F" first="F" last="Zijlstra">F. Zijlstra</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam</wicri:regionArea></affiliation></author><author><name sortKey="Caliskan, K" sort="Caliskan, K" uniqKey="Caliskan K" first="K" last="Caliskan">K. Caliskan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam</wicri:regionArea></affiliation></author><author><name sortKey="Simoons, M L" sort="Simoons, M L" uniqKey="Simoons M" first="M L" last="Simoons">M L Simoons</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam</wicri:regionArea></affiliation></author><author><name sortKey="Mourad, J J" sort="Mourad, J J" uniqKey="Mourad J" first="J J" last="Mourad">J J Mourad</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine and Arterial Hypertension, CHJ Avicenne, APHP, Bobigny, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Internal Medicine and Arterial Hypertension, CHJ Avicenne, APHP, Bobigny</wicri:regionArea></affiliation></author><author><name sortKey="Boersma, E" sort="Boersma, E" uniqKey="Boersma E" first="E" last="Boersma">E. Boersma</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam</wicri:regionArea></affiliation></author><author><name sortKey="Akkerhuis, K M" sort="Akkerhuis, K M" uniqKey="Akkerhuis K" first="K M" last="Akkerhuis">K M Akkerhuis</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam</wicri:regionArea></affiliation></author></analytic><series><title level="j">International journal of cardiology</title><idno type="eISSN">1874-1754</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age Factors</term><term>Aged</term><term>Angiotensin-Converting Enzyme Inhibitors (adverse effects)</term><term>Cough (chemically induced)</term><term>Cough (diagnosis)</term><term>Cough (epidemiology)</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Perindopril (adverse effects)</term><term>Predictive Value of Tests</term><term>Sex Factors</term><term>Vascular Diseases (drug therapy)</term><term>Vascular Diseases (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Facteurs de l'âge</term><term>Facteurs sexuels</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Inhibiteurs de l'enzyme de conversion de l'angiotensine (effets indésirables)</term><term>Maladies vasculaires (traitement médicamenteux)</term><term>Maladies vasculaires (épidémiologie)</term><term>Mâle</term><term>Périndopril (effets indésirables)</term><term>Sujet âgé</term><term>Toux ()</term><term>Toux (diagnostic)</term><term>Toux (épidémiologie)</term><term>Valeur prédictive des tests</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Angiotensin-Converting Enzyme Inhibitors</term><term>Perindopril</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Cough</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cough</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Toux</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Vascular Diseases</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Inhibiteurs de l'enzyme de conversion de l'angiotensine</term><term>Périndopril</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cough</term><term>Vascular Diseases</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Maladies vasculaires</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Maladies vasculaires</term><term>Toux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Age Factors</term><term>Aged</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Predictive Value of Tests</term><term>Sex Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Facteurs de l'âge</term><term>Facteurs sexuels</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Sujet âgé</term><term>Toux</term><term>Valeur prédictive des tests</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Our objective was to investigate the actual incidence and clinical determinants of cough leading to discontinuation of ACE-inhibitors. Cough is the most frequent reason to stop ACE-inhibitor treatment.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25189490</PMID><DateCreated><Year>2014</Year><Month>10</Month><Day>13</Day></DateCreated><DateCompleted><Year>2015</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2014</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>176</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Oct</Month><Day>20</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int. J. Cardiol.</ISOAbbreviation></Journal><ArticleTitle>The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease.</ArticleTitle><Pagination><MedlinePgn>718-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2014.07.108</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(14)01318-7</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Our objective was to investigate the actual incidence and clinical determinants of cough leading to discontinuation of ACE-inhibitors. Cough is the most frequent reason to stop ACE-inhibitor treatment.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We studied 27,492 ACE-inhibitor naïve patients randomized to the ACE-inhibitor perindopril or placebo using individual data of 3 clinical trials. Multivariate logistic regression analysis was used to study the incidence of cough in relation to baseline clinical characteristics including racial background.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 27,492 patients with cardiovascular disease, 1076 patients discontinued ACE-inhibitor perindopril due to cough (3.9%), 703 patients during run-in period of 4 weeks and 373 patients during a mean four years of follow-up. Significant determinants of cough were female gender (OR 1.92 95% CI 1.68-2.18), age above 65 years (OR 1.53 95% CI 1.35-1.73), and concomitant use of lipid-lowering agents (OR 1.37; 95% CI 1.18-1.59). A simple clinical risk score composed of these 3 predictors of cough mounted to an odds ratio of 4.4 (95% CI 3.1-5.4) in the subjects with highest score (i.e. all determinants present). Racial background was not related to a differential incidence of cough in patients of Caucasian or Asian descendent (OR 1.11 95% CI 0.92-1.39).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This large combined analysis of randomized clinical trials in 27,492 patients showed an overall lower incidence of cough leading to discontinuation of ACE-inhibitors (3.9%) as compared to literature. Clinical determinants of such cough are older age, female gender and concomitant use of lipid-lowering agents. In contrast, racial differences were not related to the incidence of cough.</AbstractText><CopyrightInformation>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brugts</LastName><ForeName>J J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands. Electronic address: j.brugts@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arima</LastName><ForeName>Hisatomi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remme</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>STICARES Cardiovascular Research Institute, Rhoon, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertrand</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lille Heart Institute, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Ferrara, Salvatore Maugeri Foundation, IRCCS, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>NHLI, Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DiNicolantonio</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mid-America Heart Institute, Saint Luke's Hospital, KS City, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacMahon</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalmers</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The George Institute for Global Health, The Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute for Global Health, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zijlstra</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caliskan</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simoons</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mourad</LastName><ForeName>J J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Arterial Hypertension, CHJ Avicenne, APHP, Bobigny, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boersma</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akkerhuis</LastName><ForeName>K M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>Y5GMK36KGY</RegistryNumber><NameOfSubstance UI="D020913">Perindopril</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020913" MajorTopicYN="N">Perindopril</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014652" MajorTopicYN="N">Vascular Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE-inhibitor</Keyword><Keyword MajorTopicYN="N">Cough</Keyword><Keyword MajorTopicYN="N">Intolerance</Keyword><Keyword MajorTopicYN="N">Perindopril</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>03</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>06</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>07</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25189490</ArticleId><ArticleId IdType="pii">S0167-5273(14)01318-7</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2014.07.108</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003321 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003321 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:25189490
|texte= The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25189490" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |